• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达单纯疱疹病毒1型糖蛋白B的重组痘苗病毒可在小鼠体内诱导细胞毒性T淋巴细胞。

A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.

作者信息

McLaughlin-Taylor E, Willey D E, Cantin E M, Eberle R, Moss B, Openshaw H

机构信息

Department of Molecular Biochemistry, City of Hope National Medical Center, Duarte, California 91010.

出版信息

J Gen Virol. 1988 Jul;69 ( Pt 7):1731-4. doi: 10.1099/0022-1317-69-7-1731.

DOI:10.1099/0022-1317-69-7-1731
PMID:2839606
Abstract

Spleen cells from BALB/c (H-2d) mice vaccinated with vgB11, a recombinant vaccinia virus which expresses glycoprotein B (gB) of herpes simplex virus type 1 (HSV-1), lysed EMT6 (H-2d) target cells infected with vgB11 or with HSV-1 but did not lyse uninfected EMT6 cells or infected L-929 (H-2k) target cells. Unlabelled target cell competition of lysis showed that only syngeneic cells infected with vgB11 or HSV-1 inhibited lysis of radiolabelled HSV-1-infected targets. These results demonstrate that vgB11 induces H-2-restricted anti-HSV-1 cytotoxic T lymphocytes and that gB is the target antigen.

摘要

用vgB11(一种表达1型单纯疱疹病毒(HSV-1)糖蛋白B(gB)的重组痘苗病毒)接种的BALB/c(H-2d)小鼠的脾细胞,可裂解被vgB11或HSV-1感染的EMT6(H-2d)靶细胞,但不能裂解未感染的EMT6细胞或被感染的L-929(H-2k)靶细胞。未标记靶细胞的裂解竞争实验表明,只有被vgB11或HSV-1感染的同基因细胞能抑制放射性标记的HSV-1感染靶细胞的裂解。这些结果表明,vgB11可诱导H-2限制性抗HSV-1细胞毒性T淋巴细胞,且gB是靶抗原。

相似文献

1
A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.表达单纯疱疹病毒1型糖蛋白B的重组痘苗病毒可在小鼠体内诱导细胞毒性T淋巴细胞。
J Gen Virol. 1988 Jul;69 ( Pt 7):1731-4. doi: 10.1099/0022-1317-69-7-1731.
2
Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins.使用表达单纯疱疹病毒(HSV)糖蛋白的腺病毒载体研究针对HSV的细胞毒性T淋巴细胞。
J Gen Virol. 1990 Feb;71 ( Pt 2):387-96. doi: 10.1099/0022-1317-71-2-387.
3
The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization.识别糖蛋白C的单纯疱疹病毒特异性细胞毒性T淋巴细胞(Tc)的比例在不同小鼠个体之间存在差异,且取决于免疫方式。
Viral Immunol. 1993 Spring;6(1):21-33. doi: 10.1089/vim.1993.6.21.
4
Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.表达单纯疱疹病毒糖蛋白gC但不表达gB、gD或gE的细胞可被鼠源病毒特异性细胞毒性T淋巴细胞识别。
J Virol. 1987 Aug;61(8):2438-47. doi: 10.1128/JVI.61.8.2438-2447.1987.
5
Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB.由表达人巨细胞病毒糖蛋白B(gB)的腺病毒和痘苗病毒重组体诱导的针对人巨细胞病毒糖蛋白B(gB)的小鼠细胞毒性T细胞反应。
J Gen Virol. 1993 Nov;74 ( Pt 11):2507-12. doi: 10.1099/0022-1317-74-11-2507.
6
The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.表达单纯疱疹病毒1型糖蛋白D的痘苗病毒重组体诱导的抗病毒免疫机制:局部感染的清除
J Immunol. 1987 May 15;138(10):3431-7.
7
Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.使用表达1型单纯疱疹病毒糖蛋白克隆基因的痘苗病毒重组体评估抗病毒免疫力。
J Gen Virol. 1989 Jun;70 ( Pt 6):1359-70. doi: 10.1099/0022-1317-70-6-1359.
8
Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.针对细胞蛋白中表达的单纯疱疹病毒特异性细胞毒性T淋巴细胞(CTL)表位的CTL应答的诱导与持续。
Virology. 1996 Aug 1;222(1):269-74. doi: 10.1006/viro.1996.0419.
9
Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.病毒特异性细胞毒性T淋巴细胞对H-2b单倍型小鼠细胞表面单纯疱疹病毒抗原的识别。
J Immunol. 1984 Jan;132(1):475-81.
10
Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.用重组痘苗病毒表达和鉴定单纯疱疹病毒1型(HSV-1)糖蛋白G(gG):用抗gG抗体中和HSV-1感染性
J Gen Virol. 1987 Oct;68 ( Pt 10):2587-98. doi: 10.1099/0022-1317-68-10-2587.

引用本文的文献

1
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors.报告基因在痘苗病毒衍生载体构建中的应用
Viruses. 2016 May 21;8(5):134. doi: 10.3390/v8050134.
2
Developments in herpes simplex virus vaccines: old problems and new challenges.单纯疱疹病毒疫苗的进展:旧问题与新挑战。
Folia Microbiol (Praha). 2006;51(2):67-85. doi: 10.1007/BF02932160.
3
Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection.1型单纯疱疹病毒特异性细胞毒性T淋巴细胞的武装发生在引流皮肤感染部位的淋巴结内。
J Virol. 2000 Mar;74(5):2414-9. doi: 10.1128/jvi.74.5.2414-2419.2000.
4
The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.C57BL/6小鼠对1型单纯疱疹病毒感染的细胞毒性T细胞反应几乎完全针对单一免疫显性决定簇。
J Virol. 1999 Sep;73(9):7619-26. doi: 10.1128/JVI.73.9.7619-7626.1999.
5
Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.用1型单纯疱疹病毒(HSV-1)的复制缺陷型突变体进行免疫接种可诱导CD8 +细胞毒性T淋巴细胞反应,并赋予与野生型HSV-1相当的保护水平。
J Virol. 1997 May;71(5):3534-44. doi: 10.1128/JVI.71.5.3534-3544.1997.
6
Deletion of the carboxy-terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B does not affect oligomerization, heparin-binding activity, or its ability to protect against HSV challenge.单纯疱疹病毒1型(HSV-1)糖蛋白B羧基末端的缺失并不影响其寡聚化、肝素结合活性或其抵御HSV攻击的能力。
Arch Virol. 1996;141(6):1153-65. doi: 10.1007/BF01718618.
7
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection.表达GP46/M-2的重组痘苗病毒可预防利什曼原虫感染。
Infect Immun. 1993 Aug;61(8):3351-9. doi: 10.1128/iai.61.8.3351-3359.1993.
8
Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.一种缺失必需糖蛋白的1型单纯疱疹病毒突变体的疫苗潜力。
J Virol. 1994 Feb;68(2):927-32. doi: 10.1128/JVI.68.2.927-932.1994.
9
Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias.不同的1型单纯疱疹病毒糖蛋白B特异性细胞毒性T细胞反应的特征显示出优先的Vβ偏向。
J Virol. 1995 Sep;69(9):5849-52. doi: 10.1128/JVI.69.9.5849-5852.1995.
10
Vaccinia virus vectors: new strategies for producing recombinant vaccines.痘苗病毒载体:生产重组疫苗的新策略。
Clin Microbiol Rev. 1990 Apr;3(2):153-70. doi: 10.1128/CMR.3.2.153.